CNBX Pharma effects 1:120 reverse split and cuts authorized preferred to 5M shares

CNBX Pharmaceuticals Inc.

Reverse stock split of 1:120 effective May 12, 2022; par value unchanged.
Authorized preferred shares reduced from 100,000,000 to 5,000,000.
Common stock now trades on OTCQB under new symbol CNBXD; new CUSIP 13764M209.
The reverse split was effected by filing a Certificate of Change with Nevada Secretary of State.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.